Will Oris lost a date if they do a reverse stock split

``` The deep research logic is organized as follows: Okay, let's tackle this question about whether ORIS will lose a date if they do a reverse stock split. First, I need to understand what the user is asking. They're concerned about the potential consequences of a reverse stock split for ORIS, specifically regarding their compliance with Nasdaq's listing requirements. Looking at the references provided, there's a lot of information about reverse stock splits and Nasdaq's rules. For example, references 11, 12, 13, 14, 15, 18, 20, 22, 28, and 29 discuss various companies undergoing reverse splits to comply with Nasdaq's minimum bid price. ORIS itself has faced delisting notices (reference 28) and has a history of public offerings and share consolidation plans (references 3, 4, 17). The user's question is about the timeline after a reverse split. From reference 22, there's a table showing that after a reverse split, companies have a certain period to comply. For example, HSDT had a reverse split on 20250701 and then had to maintain the price. The key here is that a reverse split doesn't automatically grant compliance; the company must still meet the $1.00 bid price for 10 consecutive days within 180 days post-split. ORIS's situation is critical. They received a delisting notice on 2025-08-29 (reference 28) with a compliance deadline of 2026-02-23. If they implement a reverse split, they get an additional 180 days (reference 18). However, the split must be done before the initial 180-day period ends. If they miss the compliance after the split, they face delisting. Also, the SEC's new rules (reference 18) limit reverse splits to a cumulative ratio of 250:1 within two years. ORIS hasn't done any splits yet, so they have room, but the timing is crucial. They need to execute the split and then maintain the price. The user's profile shows interest in NASDAQ stocks, so they're likely looking for a strategic move to keep ORIS listed. The answer needs to clarify the timeline, the risks, and the necessary steps ORIS must take. Also, mention the potential market reaction, like stock price volatility post-split. I should structure the answer with a clear conclusion first, then break down the timeline, compliance requirements, risks, and strategic considerations. Use the data from the references to support each point, citing them appropriately. Make sure to address the user's concern about losing the date, explaining that the compliance period resets but doesn't extend indefinitely. Also, check if there's any specific information about ORIS's past actions. They had a share consolidation plan in August 2025 (reference 17), which caused a price surge. Maybe they're considering a reverse split now. The answer should tie all these pieces together to provide a comprehensive analysis. ``` ### 🚨 **Conclusion** **Yes, ORIS risks losing its Nasdaq listing if it fails to regain compliance after a reverse stock split**. While a reverse split can extend the compliance timeline, it does not guarantee continued listing. ORIS must maintain a closing bid price of at least $1.00 for 10 consecutive trading days within 180 days post-split to avoid delisting . --- ### 📊 **Analysis** #### 1. **Nasdaq Compliance Timeline After Reverse Stock Split** If ORIS implements a reverse stock split, the compliance period resets, but the company must still meet the $1.00 bid price requirement within **180 days** of the split . The table below outlines the critical milestones: | **Event** | **Timeline** | |-------------------------------|-----------------------------------------------------------------------------| | **Reverse Stock Split** | Must occur before the initial 180-day compliance period expires (by **2026-02-23**) . | | **Post-Split Compliance** | 10 consecutive trading days with a closing bid price ≥ $1.00 . | | **Final Delisting Risk** | If compliance fails, Nasdaq will issue a delisting notice, with a potential appeal to the Hearings Panel . | #### 2. **Key Risks for ORIS** - **Regulatory Constraints**: Nasdaq’s 2025 rule updates limit reverse splits to a cumulative ratio of **250:1 within two years** . ORIS has no prior splits, so it has flexibility, but the timing is critical. - **Market Reaction**: Reverse splits often signal financial distress, potentially spooking investors (e.g., shares of ECD Automotive Design dropped 33.7% post-split ). - **Execution Risk**: ORIS must balance the split ratio to avoid over-dilution while meeting the $1.00 price target. #### 3. **Strategic Path Forward** | **Option** | **Pros** | **Cons** | |-------------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------| | **Reverse Stock Split** | Resets compliance timeline, aligns with Nasdaq’s requirements . | Risks short-term price volatility and investor skepticism . | | **Alternative Compliance** | Focus on organic growth (e.g., tea product expansion in China ). | Requires sustained operational performance, which ORIS has struggled with . | --- ### 📉 **Conclusion** ORIS faces a **high-risk, short-term window** to comply with Nasdaq’s listing rules. A reverse stock split buys time but does not solve underlying financial challenges. Investors should monitor ORIS’s compliance progress closely and prepare for potential delisting risks.